Global and Europe Doxorubicin Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global Doxorubicin market was valued at XX.0 million US$ in 2018, with the CAGR of 5.1%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Doxorubicin market. Describe product range of Doxorubicin, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Doxorubicin market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Doxorubicin market.

     

    By Player

    • Boryung

    • Sun Pharmaceutical Industries

    • Pfizer

    • Meiji Seika Pharma

    • Johnson & Johnson

    • Teva

    • MicroBiopharm Japan

    • Sterling

    • Synbias Pharma

    • LINGNAN Pharmaceutical

    By Type

    • Doxil

    • Caelyz

    • LipoDox

    By End-User

    • Clinical aiticancer drug

    • Scientific experiments

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Doxorubicin Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Doxorubicin Market Size and Growth Rate of Doxil from 2014 to 2026

      • 1.3.2 Global Doxorubicin Market Size and Growth Rate of Caelyz from 2014 to 2026

      • 1.3.3 Global Doxorubicin Market Size and Growth Rate of LipoDox from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Doxorubicin Market Size and Growth Rate of Clinical aiticancer drug from 2014 to 2026

      • 1.4.2 Global Doxorubicin Market Size and Growth Rate of Scientific experiments from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Doxorubicin Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Doxorubicin Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Doxorubicin Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Doxorubicin Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Doxorubicin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Doxorubicin by Major Types

      • 3.4.1 Doxorubicin Market Size and Growth Rate of Doxil

      • 3.4.2 Doxorubicin Market Size and Growth Rate of Caelyz

      • 3.4.3 Doxorubicin Market Size and Growth Rate of LipoDox

    4 Segmentation of Doxorubicin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Doxorubicin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Doxorubicin for Clinical aiticancer drug

      • 4.4.2 Market Size and Growth Rate of Doxorubicin for Scientific experiments

    5 Market Analysis by Major Regions

    • 5.1 Global Doxorubicin Production Analysis by Top Regions

    • 5.2 Global Doxorubicin Consumption Analysis by Top Regions

    • 5.3 Global Doxorubicin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Doxorubicin Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Doxorubicin Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Doxorubicin Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Doxorubicin Production, Import, Consumption and Export Analysis

    6 Product Circulation of Doxorubicin Market among Top Countries

    • 6.1 Top 5 Export Countries in Doxorubicin Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Doxorubicin Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Doxorubicin Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Doxorubicin Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Doxorubicin Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Doxorubicin Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Doxorubicin Landscape Analysis

    • 7.1 North America Doxorubicin Landscape Analysis by Top Countries

      • 7.1.1 United States Doxorubicin Market Volume and Growth Rate

      • 7.1.2 Canada Doxorubicin Market Volume and Growth Rate

      • 7.1.3 Mexico Doxorubicin Market Volume and Growth Rate

    8. Europe Doxorubicin Landscape Analysis

    • 8.1 Europe Doxorubicin Landscape Analysis by Major Types

    • 8.2 Europe Doxorubicin Landscape Analysis by Major End-Users

    • 8.3 Europe Doxorubicin Landscape Analysis by Top Countries

      • 8.3.1 Germany Doxorubicin Market Volume and Growth Rate

      • 8.3.2 UK Doxorubicin Market Volume and Growth Rate

      • 8.3.3 France Doxorubicin Market Volume and Growth Rate

      • 8.3.4 Italy Doxorubicin Market Volume and Growth Rate

      • 8.3.5 Spain Doxorubicin Market Volume and Growth Rate

      • 8.3.6 Belgium Doxorubicin Market Volume and Growth Rate

      • 8.3.7 Poland Doxorubicin Market Volume and Growth Rate

      • 8.3.8 Russia Doxorubicin Market Volume and Growth Rate

      • 8.3.9 Turkey Doxorubicin Market Volume and Growth Rate

      • 8.3.10 Netherlands Doxorubicin Market Volume and Growth Rate

      • 8.3.11 Portugal Doxorubicin Market Volume and Growth Rate

      • 8.3.12 Denmark Doxorubicin Market Volume and Growth Rate

      • 8.3.13 Finland Doxorubicin Market Volume and Growth Rate

      • 8.3.14 Iceland Doxorubicin Market Volume and Growth Rate

      • 8.3.15 Norway Doxorubicin Market Volume and Growth Rate

      • 8.3.16 Sweden Doxorubicin Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Doxorubicin Landscape Analysis

    • 9.1 Asia Pacific Doxorubicin Landscape Analysis by Top Countries

      • 9.1.1 China Doxorubicin Market Volume and Growth Rate

      • 9.1.2 Japan Doxorubicin Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Doxorubicin Market Volume and Growth Rate

      • 9.1.4 India Doxorubicin Market Volume and Growth Rate

      • 9.1.5 ASEAN Doxorubicin Market Volume and Growth Rate

      • 9.1.6 South Korea Doxorubicin Market Volume and Growth Rate

    10 LAMEA Doxorubicin Landscape Analysis

    • 10.1 LAMEA Doxorubicin Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Doxorubicin Market Volume and Growth Rate

      • 10.1.2 Brazil Doxorubicin Market Volume and Growth Rate

      • 10.1.3 North Africa Doxorubicin Market Volume and Growth Rate

      • 10.1.4 South Africa Doxorubicin Market Volume and Growth Rate

      • 10.1.5 Argentina Doxorubicin Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Boryung

      • 11.1.1 Boryung Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sun Pharmaceutical Industries

      • 11.2.1 Sun Pharmaceutical Industries Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Pfizer

      • 11.3.1 Pfizer Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Meiji Seika Pharma

      • 11.4.1 Meiji Seika Pharma Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Johnson & Johnson

      • 11.5.1 Johnson & Johnson Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Teva

      • 11.6.1 Teva Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 MicroBiopharm Japan

      • 11.7.1 MicroBiopharm Japan Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sterling

      • 11.8.1 Sterling Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Synbias Pharma

      • 11.9.1 Synbias Pharma Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 LINGNAN Pharmaceutical

      • 11.10.1 LINGNAN Pharmaceutical Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 123 Figures and 134 Tables)

    • Figure Product Picture

    • Figure Doxorubicin Market Size and Growth Rate of Doxil from 2014 to 2026

    • Figure Doxorubicin Market Size and Growth Rate of Caelyz from 2014 to 2026

    • Figure Doxorubicin Market Size and Growth Rate of LipoDox from 2014 to 2026

    • Figure Global Doxorubicin Market Size and Growth Rate of Clinical aiticancer drug from 2014 to 2026

    • Figure Global Doxorubicin Market Size and Growth Rate of Scientific experiments from 2014 to 2026

    • Figure North America Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure United States Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure UK Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure France Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure China Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure India Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Doxorubicin Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Doxorubicin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Doxorubicin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Doxorubicin by Different Types from 2014 to 2026

    • Table Consumption Share of Doxorubicin by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Doxil

    • Figure Market Size and Growth Rate of Caelyz

    • Figure Market Size and Growth Rate of LipoDox

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Doxorubicin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Doxorubicin by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinical aiticancer drug

    • Figure Market Size and Growth Rate of Scientific experiments

    • Table Global Doxorubicin Production by Major Regions

    • Table Global Doxorubicin Production Share by Major Regions

    • Table Global Doxorubicin Consumption by Major Regions

    • Table Global Doxorubicin Consumption Share by Major Regions

    • Table North America Doxorubicin Production, Import, Consumption and Export Analysis

    • Table Europe Doxorubicin Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Doxorubicin Production, Import, Consumption and Export Analysis

    • Table LAMEA Doxorubicin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Doxorubicin Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Doxorubicin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Doxorubicin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Doxorubicin Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Doxorubicin Consumption by Major Countries from 2014 to 2026

    • Table North America Doxorubicin Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Doxorubicin Consumption Share by Major Countries in 2014

    • Figure North America Doxorubicin Consumption Share by Major Countries in 2018

    • Figure North America Doxorubicin Consumption Share by Major Countries in 2026

    • Figure United States Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Doxorubicin Consumption by Types from 2014 to 2026

    • Table Europe Doxorubicin Consumption Share by Types from 2014 to 2026

    • Table Europe Doxorubicin Consumption by End-Users from 2014 to 2026

    • Table Europe Doxorubicin Consumption Share by End-Users from 2014 to 2026

    • Table Europe Doxorubicin Consumption by Major Countries from 2014 to 2026

    • Table Europe Doxorubicin Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure France Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Doxorubicin Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Doxorubicin Consumption Share by Major Countries from 2014 to 2026

    • Figure China Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure India Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Doxorubicin Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Doxorubicin Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Doxorubicin Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Boryung

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boryung

    • Figure Sales and Growth Rate Analysis of Boryung

    • Figure Revenue and Market Share Analysis of Boryung

    • Table Product and Service Introduction of Boryung

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries

    • Table Product and Service Introduction of Sun Pharmaceutical Industries

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Meiji Seika Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meiji Seika Pharma

    • Figure Sales and Growth Rate Analysis of Meiji Seika Pharma

    • Figure Revenue and Market Share Analysis of Meiji Seika Pharma

    • Table Product and Service Introduction of Meiji Seika Pharma

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of MicroBiopharm Japan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroBiopharm Japan

    • Figure Sales and Growth Rate Analysis of MicroBiopharm Japan

    • Figure Revenue and Market Share Analysis of MicroBiopharm Japan

    • Table Product and Service Introduction of MicroBiopharm Japan

    • Table Company Profile and Development Status of Sterling

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sterling

    • Figure Sales and Growth Rate Analysis of Sterling

    • Figure Revenue and Market Share Analysis of Sterling

    • Table Product and Service Introduction of Sterling

    • Table Company Profile and Development Status of Synbias Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synbias Pharma

    • Figure Sales and Growth Rate Analysis of Synbias Pharma

    • Figure Revenue and Market Share Analysis of Synbias Pharma

    • Table Product and Service Introduction of Synbias Pharma

    • Table Company Profile and Development Status of LINGNAN Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LINGNAN Pharmaceutical

    • Figure Sales and Growth Rate Analysis of LINGNAN Pharmaceutical

    • Figure Revenue and Market Share Analysis of LINGNAN Pharmaceutical

    • Table Product and Service Introduction of LINGNAN Pharmaceutical

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.